Petra Pharma Receives $48,000,000 Series A Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=326836f8-36cc-491f-a7b5-e4653c19db63 - Date
1/7/2016 - Company Name
Petra Pharma - Mailing Address
450 E. 29th St. New York, NY 10016 USA - Company Description
Petra Pharma’s approach interrogates the novel enzyme targets responsible for a variety of important cellular processes, including cell division, growth, trafficking and signaling to develop therapies to improve patient health. - Website
Undisclosed
- Transaction Type
Venture Equity - Transaction Amount
$48,000,000 - Transaction Round
Series A - Proceeds Purposes
Proceeds will be used to develop small molecule inhibitors for the treatment of cancer and metabolic diseases in alliance with Weill Cornell Medicine. - M&A Terms
- Venture Investor
Accelerator Ventures - Venture Investor
Investor - Venture Investor
Johnson & Johnson Development Corporation - Venture Investor
AbbVie Biotech Ventures - Venture Investor
Pfizer Venture Investments - Venture Investor
ARCH Venture Partners
